Clinical Study
The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Figure 3
Changes in TBUT in the rebamipide-treated group and control group. Treatment with rebamipide partially but significantly increased TBUT at 8 weeks, although no significant differences were observed at 4 weeks. However, no significant difference was observed in the control group. .